Trial intelligence / Profile preview

Propofol in Obese Children

NCT01242241Phase 3Completed

Sponsor
Baylor College of Medicine
Start
Apr 2008
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of propofol (2 arms), sponsored by Baylor College of Medicine. Primary endpoint: Effective Dose in 95% of patients. Started Apr 2008; status: completed.

02

Drugs

propofol

Beyond the preview

Go deeper on NCT01242241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01242241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call